Patient Selection is Critical When Evaluating Candidates for 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy (SMART) for Locally Advanced Pancreatic Cancer

被引：0
|
作者：
Lakomy, D. S. [1 ]
Schiff, J. P. [1 ]
D'Souza, A. [2 ]
Kang, K. H. [1 ]
DeSelm, C. J. [1 ]
Henke, L. E. [3 ]
Badiyan, S. N. [1 ]
Fields, R. C. [4 ]
Grierson, P. [5 ]
Kim, H. [6 ]
机构：
[1] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA
[2] Washington Univ St Louis, Sch Med, St Louis, MO USA
[3] Case Western Reserve Univ, Univ Hosp, Dept Radiat Oncol, Cleveland, OH USA
[4] Washington Univ, Sch Med, Dept Surg, St Louis, MO USA
[5] Washington Univ St Louis, Div Med Oncol, St Louis, MO USA
[6] Washington Univ St Louis, Sch Med, Dept Radiat Oncol, St Louis, MO USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2680
引用
收藏
页码：E311 / E312
页数：2
相关论文
共 30 条
  • [21] Stereotactic Body Radiotherapy (SBRT) to Localised Prostate Cancer in the Era of MRI-Guided Adaptive Radiotherapy: Doses Delivered in the HERMES Trial Comparing Two- and Five-Fraction Treatments
    Westley, Rosalyne
    Casey, Francis
    Mitchell, Adam
    Alexander, Sophie
    Nill, Simeon
    Murray, Julia
    Ratnakumaran, Ragu
    Pathmanathan, Angela
    Oelfke, Uwe
    Dunlop, Alex
    Tree, Alison C.
    CANCERS, 2024, 16 (11)
  • [22] Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort
    Doppenberg, D.
    Lagerwaard, F. J.
    van Dieren, S.
    Meijerink, M. R.
    van der Vliet, J. J.
    Besselink, M. G.
    van Tienhoven, G.
    Versteijne, E.
    Slotman, B. J.
    Wilmink, J. W.
    Kazemier, G.
    Bruynzeel, A. M. E.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [23] MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial
    Timmer, Florentine E. F.
    Geboers, Bart
    Ruarus, Alette H.
    Vroomen, Laurien G. P. H.
    Schouten, Evelien A. C.
    Lei, Susan van der
    Vos, Danielle J. W.
    Dijkstra, Madelon
    Schulz, Hannah H.
    Bakker, Joyce
    Bemd, Bente A. T. van den
    Tol, Petrousjka M. van den
    Puijk, Robbert S.
    Lissenberg-Witte, Birgit, I
    Gruijl, Tanja D. de
    Vries, Jan J. J. de
    Lagerwaard, Frank J.
    Scheffer, Hester J.
    Bruynzeel, Anna M. E.
    Meijerink, Martijn
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (05): : 448 - 459
  • [24] Sequential treatment with gemcitabine/nab-paclitaxel (GA) and FOLFIRINOX (FFX) followed by stereotactic MRI-guided adaptive radiation therapy (SMART) in patients with locally advanced pancreatic cancer (LAPC): GABRINOX-ART phase 2, multicenter trial
    Portales, Fabienne
    Ychou, Marc
    Samalin, Emmanuelle
    Assenat, Eric
    Obled, Stephane
    Tyran, Marguerite
    Mitry, Emmanuel
    Rouffiac, Magali
    Ghiringhelli, Francois
    Bachet, Jean-Baptiste
    Simon, Jean-Marc
    De Ridder, Mark
    Fiess, Catherine
    Moussion, Aurore
    Delaine, Stephanie
    Grigorescu, Florin
    Gourgou, Sophie
    Riou, Olivier
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] Proton Image-guided Radiation Assignment for Therapeutic Escalation via Selection of locally advanced head and neck cancer patients [PIRATES]: A Phase I safety and feasibility trial of MRI-guided adaptive particle radiotherapy
    van Dijk, Lisanne, V
    Frank, Steven J.
    Yuan, Ying
    Gunn, Brandon
    Moreno, Amy C.
    Mohamed, Abdallah S. R.
    Preston, Kathryn E.
    Qing, Yun
    Spiotto, Michael T.
    Morrison, William H.
    Lee, Anna
    Phan, Jack
    Garden, Adam S.
    Rosenthal, David, I
    Langendijk, Johannes A.
    Fuller, Clifton D.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 32 : 35 - 40
  • [26] Multi-institutional outcomes of patients aged 75 years and older with pancreatic ductal adenocarcinoma treated with ablative 5-fraction stereotactic magnetic resonance image-guided adaptive radiation therapy (SMART)
    Chuong, Michael David
    Palm, Russell
    Herrera, Roberto
    Rubens, Muni
    Bryant, John Michael
    Hoffe, Sarah E.
    Kim, Dae Won
    Kaiser, Adeel
    Ucar, Antonio
    Fleming, Jason B.
    De Zarraga, Fernando I.
    Hodul, Pamela Joy
    Aparo, Santiago
    Asbun, Horacio
    Malafa, Mokenge Peter
    Jimenez, Ramon
    Denbo, Jason
    Frakes, Jessica M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [27] Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)
    Bryant, J. M.
    Palm, Russell F.
    Herrera, Roberto
    Rubens, Muni
    Hoffe, Sarah E.
    Kim, Dae Won
    Kaiser, Adeel
    Ucar, Antonio
    Fleming, Jason
    De Zarraga, Fernando
    Hodul, Pamela
    Aparo, Santiago
    Asbun, Horacio
    Malafa, Mokenge
    Jimenez, Ramon
    Denbo, Jason
    Frakes, Jessica M.
    Chuong, Michael D.
    CANCER CONTROL, 2023, 30
  • [28] Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study
    Chuong, Michael D.
    Lee, Percy
    Low, Daniel A.
    Kim, Joshua
    Mittauer, Kathryn E.
    Bassetti, Michael F.
    Glide-Hurst, Carri K.
    Raldow, Ann C.
    Yang, Yingli
    Portelance, Lorraine
    Padgett, Kyle R.
    Zaki, Bassem
    Zhang, Rongxiao
    Kim, Hyun
    Henke, Lauren E.
    Price, Alex T.
    Mancias, Joseph D.
    Williams, Christopher L.
    Ng, John
    Pennell, Ryan
    Pfeffer, M. Raphael
    Levin, Daphne
    Muellerm, Adam C.
    Mooneym, Karen E.
    Kellyn, Patrick
    Shahn, Amish P.
    Boldrini, Luca
    Placidi, Lorenzo
    Fuss, Martin
    Parikh, Parag Jitendra
    RADIOTHERAPY AND ONCOLOGY, 2024, 191
  • [29] Long-Term Multi-Institutional Outcomes of 5-Fraction Ablative Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) for Inoperable Pancreas Cancer With Median Prescribed Biologically Effective Dose of 100 Gy10
    Chuong, M. D.
    Kirsch, C.
    Herrera, R.
    Rubens, M.
    Gungor, G.
    Schaff, E. M.
    Dolan, J.
    Kim, J.
    Mittauer, K. E.
    Kotecha, R.
    Gutierrez, A.
    Doemer, A. J.
    Ugurluer, G.
    Kwon, D.
    Khan, G.
    Alvarez, D.
    Ucar, A.
    Asbun, H.
    Ozyar, E.
    Parikh, P. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S147 - S148
  • [30] Stereotactic MR-Guided On-Table Adaptive Radiation Therapy (SMART) for Patients with Borderline or Locally Advanced Pancreatic Cancer: Primary Endpoint Outcomes of a Prospective Phase II Multi-Center International Trial
    Parikh, P. J.
    Lee, P.
    Low, D.
    Kim, J.
    Mittauer, K. E.
    Bassetti, M. F.
    Glide-Hurst, C.
    Raldow, A.
    Yang, Y.
    Portelance, L.
    Zaki, B.
    Kim, H.
    Mancias, J. D.
    Ng, J.
    Pfeffer, R. M.
    Mueller, A.
    Kelly, P.
    Boldrini, L.
    Fuss, M., Jr.
    Chuong, M. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (05): : 1062 - 1063
123